Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Liabilities (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Total Liabilities readings, the most recent being $1.5 million for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 18.4% to $1.5 million in Q1 2026 year-over-year; TTM through Feb 2026 was $1.5 million, a 18.4% increase, with the full-year FY2025 number at $1.2 million, up 5.22% from a year prior.
  • Total Liabilities reached $1.5 million in Q1 2026 per CBIH's latest filing, up from $1.4 million in the prior quarter.
  • The five-year high for Total Liabilities was $1.5 million in Q1 2026, with the low at $405301.0 in Q4 2022.
  • A 5-year average of $1.0 million and a median of $1.1 million in 2024 define the central range for Total Liabilities.
  • Year-over-year, Total Liabilities soared 132.85% in 2023 and then rose 5.22% in 2025.
  • Year by year, Total Liabilities stood at $405301.0 in 2022, then soared by 132.85% to $943726.0 in 2023, then grew by 27.11% to $1.2 million in 2024, then rose by 15.48% to $1.4 million in 2025, then rose by 6.02% to $1.5 million in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Total Liabilities are $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.3 million (Q3 2025).